Timothy Craig
Overview
Explore the profile of Timothy Craig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
2484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christiansen S, Banerji A, Bernstein J, Busse P, Craig T, Li H, et al.
J Allergy Clin Immunol Pract
. 2025 Mar;
PMID: 40057189
Hereditary angioedema with normal C1 inhibitor (HAE-nl-C1INH) was initially described almost a quarter century ago. Considerable progress towards unraveling the mysteries of this complex disease has been made during the...
2.
Craig T, Baptist A, Anderson J, Zaragoza-Urdaz R, Burnette A, Kelbel T, et al.
Ann Allergy Asthma Immunol
. 2025 Jan;
PMID: 39842773
Background: Hereditary angioedema (HAE) is a rare disorder in which unpredictable angioedema attacks significantly affect patient quality of life. Information on patient experiences and perspectives of HAE management within underrepresented...
3.
Matheny M, Craig T, Al-Shaikhly T
Allergy Asthma Proc
. 2024 Dec;
46(1):11-18.
PMID: 39741373
Patients with mast cell activation syndrome (MCAS) can be refractory to standard antimediator therapy. Alternative treatment options to reduce disease burden and improve quality of life are needed. To compile...
4.
Christiansen S, OConnor M, Craig T, Radojicic C, Wedner H, Danese S, et al.
Ann Allergy Asthma Immunol
. 2024 Dec;
PMID: 39694088
Background: Hereditary angioedema (HAE) is clinically characterized by recurrent attacks of subcutaneous and submucosal swelling. Objective: To investigate real-world timing, potential barriers, and impact of delaying on-demand treatment (OD) of...
5.
Ninakanti R, Borah R, Craig T, Ciocarlan R, Cool P, Bals S, et al.
ACS Nano
. 2024 Nov;
18(49):33430-33440.
PMID: 39608863
Plasmonic core-shell nanostructures can make photocatalysis more efficient for several reasons. The shell imparts stability to the nanoparticles, light absorption is expanded, and electron-hole pairs can be separated more effectively,...
6.
Duong-Quy S, Huynh-Truong-Anh D, Tang-Thi-Thao T, Nguyen-Ngoc-Phuong T, Hoang-Phi-Tuyet P, Nguyen-Tuan A, et al.
Pulm Ther
. 2024 Oct;
10(4):451-468.
PMID: 39422832
Introduction: Most hospitalized patients required invasive or non-invasive ventilation and High Flow Nasal Cannula (HFNC). Therefore, this study was conducted to describe the characteristics of patients with severe Coronavirus Disease-2019...
7.
Valerieva A, Caballero T, Magerl M, Frade J, Audhya P, Craig T
Clin Transl Allergy
. 2024 Sep;
14(9):e12391.
PMID: 39331535
Background: Hereditary angioedema (HAE) is a rare genetic disorder characterized by unpredictable, debilitating episodes of submucosal and/or subcutaneous tissue swelling, which may be life-threatening depending on anatomic location. The two...
8.
Matheny M, Craig T, Clark J
Case Rep Urol
. 2024 Sep;
2024:9172329.
PMID: 39295925
Acquired angioedema with low C1-inhibitor (AAE-C1-INH) is a rare disorder characterized by an acquired deficiency in the C1 esterase inhibitor (C1-INH). This case report describes a 79-year-old patient presenting to...
9.
Craig T, Tachdjian R, Bernstein J, Anderson J, Nurse C, Watt M, et al.
Ann Allergy Asthma Immunol
. 2024 Aug;
133(6):712-719.e1.
PMID: 39128590
Background: Lanadelumab was well tolerated and effective in preventing hereditary angioedema (HAE) attacks in the phase 3, double-blind, placebo-controlled Hereditary angioEdema Long-term Prophylaxis (HELP) study and subsequent HELP open-label extension...
10.
Riedl M, Tachdjian R, Lumry W, Craig T, Karakaya G, Gelincik A, et al.
N Engl J Med
. 2024 May;
391(1):21-31.
PMID: 38819395
Background: Hereditary angioedema is a rare disorder characterized by episodic, potentially life-threatening swelling caused by kallikrein-kinin dysregulation. Long-term prophylaxis can stabilize this system. Donidalorsen, an antisense oligonucleotide, specifically reduces prekallikrein...